SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

Nvidias board investigation into CEO Jensen Huangs admitted affair with a businesswoman reportedly suspected by U.S. intelligence of ties to China has raised concerns about leadership stability and possible national-security or disclosure issues. Traders are divided: some fear Huang could leave and uncertainty could persist, while others view the controversy as separate from Nvidias chip demand and are buying the pullback.

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Hims & Hers Health Inc - Ordinary Shares - Class A

Hims & Hers Health Inc

A sharp selloff ahead of quarterly results has traders speculating about an unverified earnings leak, while debate centers on whether the Lilly obesity-drug partnership can boost growth or pressure margins as Hims shifts toward branded GLP-1s. Some see the deal as a positive growth catalyst, but uncertainty about margins and guidance is weighing on sentiment.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs record quarterly results, higher full-year revenue outlook and expanding backlog are driving attention, with traders also pointing to progress on government and NVIDIA partnerships. Many welcome the growth and recent rebound, while others question cash burn, dilution and how much of the reported growth reflects acquisitions.

The Trade Desk, Inc. engages in the provision of a self-service and cloud-based ad-buying platform. The firm operates through the following geographical segments: United States and International. It offers omnichannel advertising, audience targeting, solutions for identity, application programming interface (API), custom, and programmatic, measurement and optimization. The company was founded by Jeffrey Terry Green and David Pickles in November 2009 and is headquartered in Ventura, CA.

Trade Desk Inc - Ordinary Shares - Class A

Trade Desk Inc

TTDs sharp pre-earnings rally is driving attention, with traders debating whether short covering or hopes for an earnings surprise are behind the move; rumors of an earnings leak remain unconfirmed. Bulls see room for a recovery, while skeptics point to weak growth expectations and the risk that results or guidance disappoint.

Candel Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development and commercialization of viral immunotherapies. Its pipeline includes CAN-2409 and CAN-3110. The company was founded by Estuardo Aguilar-Cordova in 2002 and is headquartered in Needham, MA.

Candel Therapeutics Inc

Candels positive Phase 3 prostate-cancer results and recent immune-activation and viral-shedding data are drawing attention as traders look ahead to the planned CAN-2409 BLA filing. Bulls see the data as strengthening the regulatory case, while skeptics focus on filing execution, the CEOs transparency, and potential dilution amid weak price action.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricors HOPE-3 cardiac results receiving an American Heart Association research award has renewed attention on deramiocel, while traders focus on the FDAs pending decision on the DMD treatment, especially its upper-limb-function data. The community is divided between expecting approval and warning that the FDA review remains a high-risk binary event; whether cardiac benefits appear on the label is also debated.

Take-Two Interactive Software, Inc. engages in the development, publishing, and marketing of interactive software games. Its products are designed for console systems, handheld gaming systems, and personal computers, including smart phones and tablets, and are delivered through physical retail, digital download, online platforms, and cloud streaming services. The company was founded by Ryan A. Brant in 1993 and is headquartered in New York, NY.

Take-Two Interactive Software, Inc.

Take-Twos earnings outlook and the approaching GTA VI launch dominate discussion, with traders focused on preorder demand, guidance and the games potential recurring online revenue. Bulls see the release as a major growth catalyst, while skeptics worry that expectations are already priced in and the stock could sell off if results or launch commentary disappoint.

Firefly Aerospace, Inc. engages in the design and manufacture of space launch vehicles. The company was founded by Thomas E. Markusic, Mark Watt, and Max Polyakov in January 2017 and is headquartered in Leander, TX.

Firefly Aerospace Inc.

Fireflys AST SpaceMobile agreement to supply engines, license propulsion technology, and provide engineering support for the planned Blacklift rocket is driving attention, with traders viewing the large contract as a boost to backlog and validation of its engine business. Optimism is tempered by questions about execution, the value of AST shares in the deal, and what earnings guidance will show; NASAs CLPS 2 selection adds to the bullish discussion.

Advanced Micro Devices, Inc. engages in the semiconductor business. Its products include processors, accelerators, graphics, adaptive SoCs, FPGAs, and SOMs, and software, tools, and apps. The firm offers artificial intelligence, industries, workloads, and gaming solutions. The company was founded by W. J. Sanders III on May 1, 1969 and is headquartered in Santa Clara, CA.

Advanced Micro Devices Inc.

Advanced Micro Devices Inc

AMDs rebound is drawing support from Oppenheimers upgrade and traders focus on Google Cloud using AMD EPYC processors in its AI infrastructure; many also see the Nvidia CEO controversy as prompting some rotation toward AMD. The rally has met skepticism from traders who view the move as overextended or question AMDs valuation.

TG Therapeutics, Inc. engages in the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its product pipeline includes TG-1501, TG-1701, Ublituximab, and Umbralisib. The company was founded by Michael Sean Weiss and Laurence H. Shaw on May 18, 1993 and is headquartered in Morrisville, NC.

TG Therapeutics Inc

A strong quarterly report, driven by BRIUMVI sales growth and a raised full-year revenue outlook, is the main focus; shares fell despite the results, prompting debate over a sell-the-news reaction, short-selling, and broader market pressure. Bulls are buying the pullback and point to Phase 3 results for subcutaneous BRIUMVI as a future catalyst.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$SIMO a controller inside a drive nobody bought yet is not demand, it is inventory waiting for a device cycle. seems like halls can be announced in a day, devices still have to be bought one by one

StockTwits Web

Silicon Motion Technology Corp.

 a controller inside a drive nobody bought yet is not demand, it is inventory waiting for a device cycle. seems like halls can be announced in a day, devices still have to be bought one by one